The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
The Associated Press on MSN10d
FDA approves first new class of painkiller in 20 years, a non-addictive opioid alternativeThe medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids, which are often available as generics for $1 or less. Vertex began researching ...
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids, which are often available as generics for $1 or less. Vertex began researching ...
Boston.com on MSN10d
F.D.A. Approves Drug to Treat Pain Without Opioid EffectsThe drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids, which are often available as generics for $1 or less. Vertex began researching ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback